Kalaris Therapeutics, Inc. - KLRS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$151.9M
QoQ value delta ($000)
+$75.45M (+98.73%)
Implied price effect (QoQ)
+46.02%
Shares
Total shares
17,996,169
QoQ shares delta
+4,773,296 (+36.1%)
Total shares held by funds (by quarter)

Market chart (KLRS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Samsara BioCapital, LLC 109,281 12,948,081 11.27%
RTW INVESTMENTS, LP 10,972 1,300,000 0.11%
Paradigm Biocapital Advisors LP 5,908 700,000 0.15%
Siren, L.L.C. 3,678 435,798 0.11%
Alyeska Investment Group, L.P. 3,402 403,551 0.01%
Ikarian Capital, LLC 3,038 360,000 0.24%
VANGUARD GROUP INC 2,471 292,790 0.0%
Kalehua Capital Management LLC 1,180 139,901 1.17%
Woodline Partners LP 844 100,000 0.0%
ADAR1 Capital Management, LLC 844 100,000 0.06%
WHI TRUST Co LLC 822 97,493 0.63%
BOOTHBAY FUND MANAGEMENT, LLC 778 92,261 0.01%
RAYMOND JAMES FINANCIAL INC 746 88,436 0.0%
RENAISSANCE TECHNOLOGIES LLC 740 87,751 0.0%
Redmile Group, LLC 700 82,955 0.05%
GEODE CAPITAL MANAGEMENT, LLC 697 82,647 0.0%
683 Capital Management, LLC 680 80,590 0.03%
MARSHALL WACE, LLP 615 72,876 0.0%
Propel Bio Management, LLC 354 42,053 0.3%
Belpointe Asset Management LLC 337 40,000 0.01%
Fortis Capital Advisors, LLC 337 40,000 0.05%
BlackRock, Inc. 324 38,454 0.0%
GOLDMAN SACHS GROUP INC 289 34,303 0.0%
JANE STREET GROUP, LLC 279 33,114 0.0%
OMERS ADMINISTRATION Corp 253 30,000 0.0%